| Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. SC Morris, KB Madden, JJ Adamovicz, WC Gause, BR Hubbard, ... Journal of immunology (Baltimore, Md.: 1950) 152 (3), 1047-1056, 1994 | 373 | 1994 |
| Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine DG Heath, GW Anderson Jr, JM Mauro, SL Welkos, GP Andrews, ... Vaccine 16 (11-12), 1131-1137, 1998 | 363 | 1998 |
| Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts PA Arlen, M Singleton, JJ Adamovicz, Y Ding, A Davoodi-Semiromi, ... Infection and immunity 76 (8), 3640-3650, 2008 | 179 | 2008 |
| Design and testing for a nontagged F1‐V fusion protein as vaccine antigen against bubonic and pneumonic plague BS Powell, GP Andrews, JT Enama, S Jendrek, C Bolt, P Worsham, ... Biotechnology Progress 21 (5), 1490-1510, 2005 | 121 | 2005 |
| The use of the PCR to quantitate gene expression. WC Gause, J Adamovicz Genome Research 3 (6), S123-S135, 1994 | 116 | 1994 |
| Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis GP Andrews, ST Strachan, GE Benner, AK Sample, GW Anderson Jr, ... Infection and immunity 67 (3), 1533-1537, 1999 | 106 | 1999 |
| Development of In Vitro Correlate Assays of Immunity to Infection with Yersinia pestis J Bashaw, S Norris, S Weeks, S Trevino, JJ Adamovicz, S Welkos Clinical and Vaccine Immunology 14 (5), 605-616, 2007 | 85 | 2007 |
| Biodefense: research methodology and animal models JR Swearengen CRC Press, 2005 | 77 | 2005 |
| The SCID/Beige mouse as a model to investigate protection against Yersinia pestis M Green, D Rogers, P Russell, AJ Stagg, DL Bell, SM Eley, RW Titball, ... FEMS Immunology & Medical Microbiology 23 (2), 107-113, 1999 | 77 | 1999 |
| Intranasal Protollin™/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection T Jones, JJ Adamovicz, SL Cyr, CR Bolt, N Bellerose, LM Pitt, GH Lowell, ... Vaccine 24 (10), 1625-1632, 2006 | 75 | 2006 |
| TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague JS Lin, S Park, JJ Adamovicz, J Hill, JB Bliska, CK Cote, DS Perlin, ... Vaccine 29 (2), 357-362, 2010 | 65 | 2010 |
| Antibodies and cytokines independently protect against pneumonic plague LW Kummer, FM Szaba, MA Parent, JJ Adamovicz, J Hill, LL Johnson, ... Vaccine 26 (52), 6901-6907, 2008 | 65 | 2008 |
| Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of … VM Peterson, JJ Adamovicz, TB Elliott, MM Moore, GS Madonna, ... Journal of immunology (Baltimore, Md.: 1950) 153 (5), 2321-2330, 1994 | 62 | 1994 |
| Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens A Glynn, CJ Roy, BS Powell, JJ Adamovicz, LC Freytag, JD Clements Infection and immunity 73 (8), 5256-5261, 2005 | 59 | 2005 |
| CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague K Amemiya, JL Meyers, TE Rogers, RL Fast, AD Bassett, PL Worsham, ... Vaccine 27 (16), 2220-2229, 2009 | 51 | 2009 |
| Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague CO Jarrett, F Sebbane, JJ Adamovicz, GP Andrews, BJ Hinnebusch Infection and immunity 72 (4), 2052-2056, 2004 | 48 | 2004 |
| Application of carbohydrate microarray technology for the detection of Burkholderia pseudomallei, Bacillus anthracis and Francisella tularensis antibodies N Parthasarathy, R Saksena, P Kováč, D Deshazer, SJ Peacock, ... Carbohydrate research 343 (16), 2783-2788, 2008 | 41 | 2008 |
| In fectious. D isease LE Lindler, FJ Lebeda, GW Korch | 41 | 2005 |
| Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague JL Goodin, DF Nellis, BS Powell, VV Vyas, JT Enama, LC Wang, PK Clark, ... Protein expression and purification 53 (1), 63-79, 2007 | 39 | 2007 |
| CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols DA Rozak, HC Gelhaus, M Smith, M Zadeh, L Huzella, D Waag, ... Journal of immune based therapies and vaccines 8, 1-5, 2010 | 38 | 2010 |
